1. Po LW. Clinical measures of
disease severity and outcome in psoriasis: a critical appraisal of their
quality. British Journal of Dermatology. 1999 Aug;141(2):185-91. DOI:
10.1046/j.1365-2133.1999.02963x.
2. Jindal S, Awasthi R, Singare
D, Kulkarni GT. Potential Of Herbal Nanocarrier Formulation For The Treatment
Of Psoriasis. International Journal of Pharmacy & Life Sciences. 2019 Jun
1;10(6).
https://scholar.google.com/scholar?q=2)+Jindal+S,+Awasthi+R,+Singare+D,+Kulkarni+GT.+Potential+Of+Herbal+Nanocarrier+Formulation+For+The+Treatment+Of+Psoriasis.+International+Journal+of+Pharmacy+%26+Life+Sciences.+2019+Jun+1%3B10(6).&hl=en&as_sdt=0,5
3. Parisi R, Symmons DP,
Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic
review of incidence and prevalence. Journal of Investigative Dermatology. 2013,
1;133(2):377-85. https:// DOI.org/10.1038/jid.2012.339
4. Sanford JA, Gallo RL.
Functions of the skin microbiota in health and disease. InSeminars in
immunology 2013, 30 (Vol. 25, No. 5, pp. 370-377). Academic Press. https://DOI.org/10.1016/
j.smim.2013.09.005
5. Capon F. The genetic basis of
psoriasis. International Journal of Molecular Sciences. 2017;18(12):2526. https://DOI.org/10.3390/
ijms18122526
6. Finlay AY, Khan G.
Dermatology Life Quality Index (DLQI)—a simple practical measure for routine
clinical use. Clinical and experimental dermatology. 1994;19(3):210-6.
https://DOI.org/10.1111/j.1365-2230.1994.tb01167.x
7. Jindal S, Awasthi R, Singhare
D, Kulkarni GT. Topical delivery of Tacrolimus using liposome containing gel:
An emerging and synergistic approach in management of psoriasis. Medical
Hypotheses. 2020 May 15:109838. https://DOI.org/10.1016/ j.mehy.2020.109838
8. Eghlileb AM, Davies EE,
Finlay AY. Psoriasis has a major secondary impact on the lives of family
members and partners. British Journal of Dermatology. 2007;156(6):1245-50.
https://DOI.org/10.1111/j.1365-2133.2007.07881.x
9. Schadler ED, Ortel B, Mehlis
SL. Biologics for the primary care physician: review and treatment of
psoriasis. Disease-a-Month. 2019; 1;65(3):51-90. https://DOI.org/10.1016/j.disamonth.
2018.06.001
10. Rendon A, Schäkel K.
Psoriasis pathogenesis and treatment. International journal of molecular
sciences. 2019;20(6):1475. https://DOI.org/10.3390/ijms20061475
11. Avila R, Pugh DG, Slocumb CH,
Winkelmann RK. Psoriatic arthritis: a roentgenologic study. Radiology.
1960;75(5):691-702. https://DOI.org/10.1148/75.5.691
12. Nevitt GJ, Hutchinson PE.
Psoriasis in the community: prevalence, severity and patients' beliefs and
attitudes towards the disease. British Journal of Dermatology.
1996;135(4):533-7. https://DOI.org/10.1046/j.1365-2133.1996.d01-1035.x
13. Benhadou F, Mintoff D, Schnebert
B, Thio HB. Psoriasis and microbiota: a systematic review. Diseases.
2018;6(2):47. https://DOI.org/10.3390/diseases6020047
14. Davidovici BB, Sattar N, Jörg
PC, Puig L, Emery P, Barker JN, Van De Kerkhof P, Ståhle M, Nestle FO,
Girolomoni G, Krueger JG. Psoriasis and systemic inflammatory diseases:
potential mechanistic links between skin disease and co-morbid conditions.
Journal of Investigative Dermatology. 2010;1;130(7):1785-96. https://DOI.org/10.1038/jid.2010.103
15. Fortune DG, Richards HL,
Kirby B, Bowcock S, Main CJ, Griffiths CE. A cognitive‐behavioural symptom
management programme as an adjunct in psoriasis therapy. British Journal of
Dermatology. 2002;146(3):458-65. https://DOI.org/10.1046/j.1365-2133.2002.04622.x
16. Nirbhavane P, Sharma G, Verma
S, Jadon RS, Singh B, Katare OP. Nail Psoriasis Treatment: Insights into
Current Progress and Future Trends. Critical Reviews™ in Therapeutic Drug
Carrier Systems. 2020;37(2). 10.1615/CritRevTherDrugCarrierSyst.2020029259
17. Unissa R, Kumar PM, Pasha M,
Begum S, Maheswari B. Psoriasis: A Comprehensive Review. Asian Journal of
Research in Pharmaceutical Science. 2019;9(1):29-38.
18. Badanthadka M, D’Souza L.
Imiquimod-Induced Psoriasis Mice Model: A Promising Tool for Psoriasis
Research?. Research Journal of Pharmacy and Technology. 2020 Jul
28;13(7):3508-15.
19. Sumithra M, Majeed AM, Chitra
V. Cell Lines and Animal Models of Psoriasis. Research Journal of Pharmacy and
Technology. 2020;13(3):1601-8.
20. Kavitha S. Pharmacognostical
Evaluation and Standardisation of Ayurvedic Formulation Patoladi Kwatha Churna
for Psoriasis. Research Journal of Pharmacy and Technology. 2020;13(3):1171-4.
21. Taha MM, Al-Asady ZT.
Evaluation of the Effectiveness of Antioxidants and TNF-α in Iraqi Patients
with Psoriasis treated with Etanercept. Research Journal of Pharmacy and
Technology. 2019;12(2):665-8.
22. Sukare P, Bhattacharya R.
Herbal plant used in Treatment of Psoriasis-A Systematic Review. Research
Journal of Pharmacognosy and Phytochemistry. 2020;12(1):57-62.
23. Staubach P, Zimmer S. Plaque
psoriasis–more than a skin disorder. MedizinischeMonatsschrift fur
Pharmazeuten. 2017;40(6):231-3. PMID: 29979560
24. Blauvelt A. T-helper 17 cells
in psoriatic plaques and additional genetic links between IL-23 and psoriasis.
Journal of Investigative Dermatology. 2008; 1;128(5):1064-7.
https://DOI.org/10.1038/jid.2008.85
25. Asumalahti K, Ameen M,
Suomela S, Hagforsen E, Michaelsson G, Evans J, Munro M, Veal C, Allen M, Leman
J, Burden AD. Genetic analysis of PSORS1 distinguishes guttate psoriasis and
palmoplantarpustulosis. Journal of investigative dermatology.
2003;1;120(4):627-32. DOI: 10.1046/j.1523-1747.2003.12094.x.
26. KO HC, JWA SW, Song M, KIM
MB, KWON KS. Clinical course of guttate psoriasis: Long‐term follow‐up study.
The Journal of dermatology. 2010;37(10):894-9. DOI:
10.1111/j.1346-8138.2010.00871.x.
27. Navarini AA, Burden AD, Capon
F, Mrowietz U, Puig L, Köks S, Kingo K, Smith C, Barker JN, ERASPEN Network,
Bachelez H. European consensus statement on phenotypes of pustular psoriasis.
Journal of the European Academy of Dermatology and Venereology.
2017;31(11):1792-9. DOI: 10.1111/jdv.14386
28. Sommer DM, Jenisch S, Suchan
M, Christophers E, Weichenthal M. Increased prevalence of the metabolic
syndrome in patients with moderate to severe psoriasis. Archives of
dermatological research. 2007; 1;298(7):321. DOI: 10.1007/s00403-006-0703-z.
29. Benjegerdes KE, Hyde K,
Kivelevitch D, Mansouri B. Pustular psoriasis: pathophysiology and current
treatment perspectives. Psoriasis (Auckland, NZ). 2016;6:131. DOI:
10.2147/PTT.S98954
30. Micali G, Verzì AE, Giuffrida
G, Panebianco E, Musumeci ML, Lacarrubba F. Inverse Psoriasis: From Diagnosis
to Current Treatment Options. Clinical, Cosmetic and Investigational
Dermatology. 2019; 12:953. DOI: 10.2147/CCID.S189000
31. Singh RK, Lee KM, Ucmak D,
Brodsky M, Atanelov Z, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Liao W.
Erythrodermic psoriasis: pathophysiology and current treatment perspectives.
Psoriasis (Auckland, NZ). 2016;6: 93. DOI: 10.2147/PTT.S101232
32. Ayala-Fontánez N, Soler DC,
McCormick TS. Current knowledge on psoriasis and autoimmune diseases. Psoriasis
(Auckland, NZ). 2016;6: 7. DOI: 10.2147/PTT.S64950
33. Kormeili T, Lowe NJ, Yamauchi
PS. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic
therapies; US experiences. British Journal of Dermatology. 2004;151(1):3-15.
DOI: 10.1111/j.1365-2133.2004.06009.x.
34. Berekmeri A, Mahmood F,
Wittmann M, Helliwell P. Tofacitinib for the treatment of psoriasis and
psoriatic arthritis. Expert review of clinical immunology. 2018;2;14(9):719-30.
DOI: 10.1080/1744666X.2018.1512404.
35. Surjushe A, Vasani R, Saple
DG. Aloe vera: a short review. Indian journal of dermatology. 2008;53(4):163.
DOI: 10.4103/0019-5154.44785.
36. Saelee C, Thongrakard V,
Tencomnao T. Effects of Thai medicinal herb extracts with anti-psoriatic
activity on the expression on NF-κB signaling biomarkers in HaCaT
keratinocytes. Molecules. 2011;16(5):3908-32. DOI: 10.3390/molecules16053908.
37. Rout SK, Anwar S, Tripathy
BC. Nanosilver Coated Coir Based Dielectric Materials with High K and Low Df
for Embedded Capacitors and Insulating Material Applications–A Greener
Approach. ACS Sustainable Chemistry & Engineering. 2019 21;7(4):3824-37.
https://DOI.org/10.1021/acssuschemeng.8b04465
38. Parlapally S, Cherukupalli N,
Bhumireddy SR, Sripadi P, Anisetti R, Giri CC, Khareedu VR, Reddy Vudem D.
Chemical profiling and anti-psoriatic activity of methanolic extract of
Andrographisnallamalayana JL Ellis. Natural Product Research. 2016;
2;30(11):1256-61. DOI: 10.1080/14786419.2015.1054825
39. Qin JZ, Chaturvedi V, Denning
MF, Choubey D, Diaz MO, Nickoloff BJ. Role of NF-κB in the apoptotic-resistant
phenotype of keratinocytes. Journal of Biological Chemistry. 1999;
31;274(53):37957-64. DOI: 10.1074/jbc.274.53.37957
40. Pandey SS, Jha AK, Kaur V.
Aqueous extract of neem leaves in treatment of Psoriasis vulgaris. Indian
Journal of Dermatology, Venereology, and Leprology. 1994; 1;60(2):63.
http://www.ijdvl.com/text.asp?1994/60/2/63/3994
41. Damevska K, Neloska L,
Nikolovska S, Gocev G, Duma S. Complementary and alternative medicine use among
patients with psoriasis. Dermatologic therapy. 2014;27(5):281-3. DOI:
10.1111/dth.12139
42. Kapoor B, Kaur G, Gupta M,
Gupta R. Indian medicinal plants useful in treatment of gout: a review for
current status and future prospective. Asian J. Pharm. Clin. Res. 2017; 10:407.
DOI: http://dx.DOI.org/10.22159/ajpcr.2017.v10i11.20170
43. Bylka W, Znajdek-Awiżeń P,
Studzińska-Sroka E, Brzezińska M. Centellaasiatica in cosmetology. Advances in
Dermatology and Allergology/PostȩpyDermatologii I Alergologii. 2013;30(1):46.
DOI: 10.5114/pdia.2013.33378.
44. Amenta R, Camarda L, Di
Stefano V, Lentini F, Venza F. Traditional medicine as a source of new
therapeutic agents against psoriasis. Fitoterapia. 2000; 1;71: S13-20. DOI:
10.1016/s0367-326x(00)00172-6.
45. Sunil Bavaskar, Mayur Bhurat,
Vikram Mahale, Nasir Mohammad, Yogesh patil. Cassia fistula Linn. –A
Phytopharmacological Review. Research J. Pharmacognosy and Phytochemistry 2011;
3(1): 10-13.
46. Pattan SR, Dighe NS, Nirmal
SA, Chavan PA, Bhawar SB, Jadhao N, Dighe SB. An Overview of Cassia fistula:
Chemistry and Pharmacological Profile. Research Journal of Pharmacognosy and
Phytochemistry. 2009;1(3):143-5.
47. Rahman MA, Islam MS.
Antioxidant, antibacterial and cytotoxic effects of the phytochemicals of whole
Leucasaspera extract. Asian Pacific journal of tropical biomedicine.
2013;3(4):273. DOI: 10.1016/S2221-1691(13)60062-3.
48. Dighe NS, Pattan SR, Nirmal
SA, Dhasade VV, Dake SG, Shelar MU, Hole MB, Gaware V. A Review on
Phytochemical and Pharmacological Profile of Cassia tora Linn. Research Journal
of Pharmacognosy and Phytochemistry. 2009;1(3):173-6.
49. Sabale P, Modi A, Sabale V.
Curcuma longa Linn. A phytochemical and phytopharmacological review. Research
Journal of Pharmacognosy and Phytochemistry. 2013;5(2):59-68.
50. Reuter J, Wölfle U, Weckesser
S, Schempp C. Which plant for which skin disease? Part 1: Atopic dermatitis,
psoriasis, acne, condyloma and herpes simplex. JDDG: Journal der Deutschen
DermatologischenGesellschaft. 2010;8(10):788-96. DOI:
10.1111/j.1610-0387.2010.07496.x.
51. Daniyal M, Akram M, Zainab R,
Munir N, Shah SM, Liu B, Wang W, Riaz M, Jabeen F. Progress and prospects in
the management of psoriasis and developments in phyto‐therapeutic modalities.
Dermatologic therapy. 2019;32(3):e12866. DOI: 10.1111/dth.12866. Epub 2019 Mar
18.
52. Prasad V, Jain V, Girish D,
Dorle AK. Wound-healing property of Momordicacharantia L. fruit powder. Journal
of Herbal Pharmacotherapy. 2006;1;6(3-4):105-15. DOI: 10.1080/j157v06n03_05.
53. Tse WP, Che CT, Liu K, Lin
ZX. Evaluation of the anti-proliferative properties of selected
psoriasis-treating Chinese medicines on cultured HaCaT cells. Journal of
ethnopharmacology. 2006; 3;108(1):133-41. DOI: 10.1016/j.jep.2006.04.023. Epub
2006 May 5.
54. Ross SM. Milk thistle
(Silybummarianum): an ancient botanical medicine for modern times. Holistic
nursing practice. 2008; 1;22(5):299-300. DOI:
10.1097/01.HNP.0000334924.77174.6d.
55. Parlapally S, Cherukupalli N,
Bhumireddy SR, Sripadi P, Anisetti R, Giri CC, Khareedu VR, Reddy Vudem D.
Chemical profiling and anti-psoriatic activity of methanolic extract of
Andrographisnallamalayana JL Ellis. Natural Product Research.
2016;2;30(11):1256-61. DOI: 10.1080/14786419.2015.1054825
56. Wun C. Complementary
Medicine-Navigating Volume Three. Journal of Complementary Medicine: CM, The.
2005;4(1):84.
<https://search.informit.com.au/documentSummary;dn=893661027452168;res=IELHEA>